Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A cost density analysis of benign prostatic hyperplasia

S F Lanes1, S Sulsky, A M Walker

  • 1Epidemiology Resources Inc., Newton Lower Falls, Massachusetts, USA.

Clinical Therapeutics
|September 1, 1996
PubMed
Summary

Benign prostatic hyperplasia (BPH) care costs declined from 1991-1994 due to fewer prostatectomies and increased terazosin use. This shift reduced overall BPH treatment expenses, highlighting evolving treatment patterns.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent ethanol exposure reprograms HMGB1 responsivity to adult ethanol challenge in males.

Physiology & behavior·2026
Same author

Computed tomography versus radiography for assessment of canine humeral condylar fracture malreductions.

New Zealand veterinary journal·2025
Same author

Development of a novel Bluetooth Low Energy device for proximity and location monitoring in grazing sheep.

Animal : an international journal of animal bioscience·2024
Same author

Neuroprotection by anaesthetics in rodent models of traumatic brain injury: a systematic review and network meta-analysis.

British journal of anaesthesia·2018
Same author

Point-of-care paediatric gastric sonography: can antral cut-off values be used to diagnose an empty stomach?

British journal of anaesthesia·2017
Same author

A Case of Porro's Hysterectomy.

The Indian medical gazette·2017

Area of Science:

  • Urology
  • Health Economics

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
  • Understanding the costs and utilization patterns of BPH care is crucial for healthcare management.

Purpose of the Study:

  • To assess the frequency and cost of medical services for benign prostatic hyperplasia (BPH) in a large health maintenance organization.
  • To analyze trends in BPH treatment modalities and their associated healthcare expenditures over a four-year period.

Main Methods:

  • Retrospective analysis of healthcare utilization and cost data for approximately 165,000 health plan subscribers from 1991 to 1994.
  • Identification of 3919 men diagnosed with BPH and analysis of their treatment pathways, including medication (terazosin, finasteride) and surgical interventions (prostatectomy).

Related Experiment Videos

  • Estimation of care costs using Medicare reimbursement schedules and medication wholesale prices.

    • Main Results:

    • The study identified 3919 men with BPH, with 18% receiving terazosin, 6% undergoing prostatectomy, and 1% receiving finasteride.
    • Average annual BPH care costs ranged widely, with major cost components including hospital admissions (35%), terazosin (29%), and physician visits (19%).
    • Prostatectomy rates decreased by 80%, while terazosin dispensing doubled, leading to an overall reduction in total BPH care costs from 1991 to 1994.

    Conclusions:

    • Shifting treatment patterns in benign prostatic hyperplasia care, characterized by decreased prostatectomy rates and increased use of medications like terazosin, contributed to a significant decline in overall healthcare costs.
    • These findings underscore the economic impact of evolving therapeutic strategies for BPH and inform healthcare resource allocation.